Previous Section Index Home Page

22 Feb 2010 : Column 110W—continued


It is important to note that although recent meta-analyses showed that alcohol consumption was found to have protective effects on the risk of four conditions: ischaemic heart disease (IHD); ischaemic stroke, type II diabetes; and cholelithiasis, the health benefits for heart disease mostly accrue at low levels of consumption (no more than one-two units daily is needed for the main protective effect) and the benefits are mainly only seen in men over 40 years old and in postmenopausal women. Drinking above the recommended lower-risk levels, of not regularly drinking more than three-four units per day for men and not regularly drinking more than two-three units per day for women, however, does increase the risk of both ischaemic heart disease and ischaemic stroke compared to non-drinkers.

In 2008-09, there were 84,926 hospital admissions due to stroke. As there is no AAF for stroke we cannot say how many of these admissions were due to alcohol, but we can provide the number of hospital admissions for alcohol-related haemorrhagic stroke and alcohol-related ischaemic stroke as a proxy. In 2008-09, there were 2,445 admissions for alcohol-related haemorrhagic stroke and 1,197 admissions for alcohol-related ischaemic stroke.


22 Feb 2010 : Column 111W

Alzheimer's Disease: Research

Mr. Frank Field: To ask the Secretary of State for Health what funding his Department has allocated for research into the causes of Alzheimer's disease in each of the last three years. [317778]

Mr. Lammy: I have been asked to reply.

The Department for Business, Innovation and Skills does not allocate funding for specific research directly but provides funding through the research councils.

The Medical Research Council (MRC) currently funds studies into the causes, prevention and treatment of dementia, including Alzheimer's disease. These include studying drug treatment for managing symptoms, supporting tissue banks, and research into 'biomarkers' that might improve diagnosis. Other teams are investigating ways to diagnose and measure the progression of dementia and studying genes that may increase risk.

MRC expenditure on dementia research, including Alzheimer's, in the last three years was as follows:

MRC expenditure (£ million)

2006-07

6.4

2007-08

10.2

2008-09

11.5


The Biotechnology and Biological Sciences Research Council (BBSRC) supports basic biological research in neuroscience and psychology. This includes basic underpinning research that may increase understanding of the causes of Alzheimer's. Funding on this research in the last three years was as follows:

Funding (£ million)

2006-07

0.5

2007-08

0.6

2008-09

0.5


Additionally, the BBSRC funds research of relevance to amyloids, which are implicated in Alzheimer's and other neurodegenerative diseases. Funding on this research in the last three years was as follows:

Funding (£ million)

2006-07

0.4

2007-08

0.8

2008-09

0.8


Autism

Mr. Streeter: To ask the Secretary of State for Health what progress has been made by his Department in producing a national autism strategy. [317349]

Phil Hope: The legislation mandates a time frame for the publication of the strategy by 1 April 2010.


22 Feb 2010 : Column 112W

The autism strategy will be published shortly, in advance of that date.

Mr. Frank Field: To ask the Secretary of State for Health what progress has been made by his Department in producing a national autism strategy; and when he expects to issue guidance to local authorities and strategic health authorities. [317883]

Phil Hope: The Autism Act 2009 commits the Government to publishing a strategy for adults with autism no later than 1 April 2010. The autism strategy will be published shortly, in advance of that date.

The Department will consult on the content of guidance for health and social care bodies over the summer and will publish that guidance before the end of December.

Breast Cancer

Mr. Dismore: To ask the Secretary of State for Health how many deaths from breast cancer there were in the last year for which figures are available. [316289]

Angela E. Smith: I have been asked to reply.

The information requested falls within the responsibility of the UK Statistics Authority. I have asked the Authority to reply.

Letter from Stephen Penneck, dated 9 February 2010:

Table 1: Number of deaths where breast cancer was the underlying cause of death, England and Wales, 2008( 1,2,3)
Cause of death Deaths (persons)

Breast cancer

10,779

(1) Cause of death was defined using the International Classification of Diseases, Tenth Revision (ICD-10) code C50.
(2) Figures for England and Wales include deaths of non-residents.
(3) Figures are for deaths registered in each calendar year.

Breast Cancer: Hemsworth

Jon Trickett: To ask the Secretary of State for Health how many and what percentage of women resident in Hemsworth constituency with suspected breast cancer saw a specialist within two weeks of referral in each year since 1997. [316628]

Ann Keen: The information is not available in the format requested. The following table shows the number of people seen and the percentage seen within two weeks, following an urgent referral for suspected breast cancer for Barnsley Hospital NHS Foundation Trust and Mid-Yorkshire Hospitals NHS Trust.


22 Feb 2010 : Column 113W

22 Feb 2010 : Column 114W
Barnsley Hospital NHS Foundation Trust Mid Yorkshire Hospitals NHS Trust

Quarter (Q) Number Percentage Number Percentage

2001-02

Q1

98

96.1

86

69.9

Q2

111

100.0

60

42.6

Q3

121

100.0

141

88.1

Q4

122

100.0

108

100.0

2002-03

Q1

118

95.9

162

100.0

Q2

129

98.5

159

100.0

Q3

101

84.2

223

98.7

Q4

137

100.0

174

97.2

2003-04

Q1

126

100.0

181

98.9

Q2

148

100.0

241

97.6

Q3

157

100.0

208

92.9

Q4

156

100.0

215

91.1

2004-05

Q1

155

100.0

208

99.5

Q2

149

100.0

190

98.4

Q3

164

100.0

241

99.2

Q4

159

100.0

215

96.4

2005-06

Q1

199

100.0

231

98.7

Q2

180

100.0

279

98.9

Q3

188

100.0

283

100.0

Q4

190

100.0

259

100.0

2006-07

Q1

177

100.0

308

100.0

Q2

157

100.0

267

100.0

Q3

175

100.0

352

100.0

Q4

175

100.0

313

100.0

2007-08

Q1

154

100.0

288

100.0

Q2

149

100.0

307

99.7

Q3

151

100.0

424

99.8

Q4

154

100.0

363

100.0

2008-09

Q1

186

100.0

454

99.6

Q2

147

100.0

444

100.0

Q3

166

100.0

420

100.0

Q4

159

98.1

416

96.1

2009-10

Q1

177

97.3

390

95.6

Q2

158

99.4

392

97.5

Source:
Cancer Waiting Times database.

Next Section Index Home Page